comment on "Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease"

被引：0
|
作者：
Costa, Marco [1 ]
机构：
[1] Corpo Redatorial Revista Portuguesa Cardiol, Lisbon, Portugal
来源：
REVISTA PORTUGUESA DE CARDIOLOGIA | 2017年 / 36卷 / 06期
关键词：
PCSK9;
D O I：
10.1016/j.repc.2017.05.003
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：485 / 486
页数：2
相关论文
共 50 条
  • [21] Reduction in Total Cardiovascular Events With the PCSK9 Inhibitor Evolocumab in Patients With Cardiovascular Disease in the FOURIER Trial
    Murphy, Sabina A.
    Pedersen, Terje R.
    Gaciong, Zbigniew A.
    Ceska, Richard
    Ezhov, Marat V.
    Connolly, Derek
    Kraydashenko, Oleg
    Jukema, J. Wouter
    Toth, Kalman
    Tikkanen, Matti J.
    Im, Kyungah
    Wiviott, Stephen D.
    Kurtz, Christopher
    Honarpour, Narimon
    Giugliano, Robert P.
    Keech, Anthony C.
    Sever, Peter S.
    Sabatine, Marc S.
    CIRCULATION, 2017, 136
  • [22] Atherosclerotic Cardiovascular Disease and Chronic Kidney Disease An Emerging Role for Evolocumab?
    Cherney, David Z. I.
    Rosenson, Robert S.
    Lawler, Patrick R.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 73 (23) : 2971 - 2975
  • [23] IMPACT OF TRICUSPID REGURGITATION ON EXERCISE INTOLERANCE AND CLINICAL OUTCOMES IN PATIENTS WITH CARDIOVASCULAR DISEASE
    Nakamura, Kosuke
    Omote, Kazunori
    Yasui, Yutaro
    Mizuguchi, Yoshifumi
    Takenaka, Sakae
    Sato, Takuma
    Ishizaka, Suguru
    Kobayashi, Yuta
    Tada, Atsushi
    Kamiya, Kiwamu
    Nagai, Toshiyuki
    Anzai, Toshihisa
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (08) : 1346 - 1346
  • [24] Gender differences in clinical outcomes among diabetic patients hospitalized for cardiovascular disease
    Flink, Laura
    Mochari-Greenberger, Heidi
    Mosca, Lori
    AMERICAN HEART JOURNAL, 2013, 165 (06) : 972 - 978
  • [25] The clinical significance of osteopontin on the cardiovascular outcomes in patients with stable coronary artery disease
    Cheong, Kei-Ip
    Leu, Hsin-Bang
    Wu, Chau-Chung
    Yin, Wei-Hsian
    Wang, Ji-Hung
    Lin, Tsung-Hsien
    Tseng, Wei-Kung
    Chang, Kuan-Cheng
    Chu, Shu-Hsun
    Yeh, Hung-, I
    Chen, Jaw-Wen
    Wu, Yen-Wen
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2023, 122 (04) : 328 - 337
  • [26] COST-EFFECTIVENESS OF EVOLOCUMAB IN ATHEROSCLEROTIC CARDIOVASCULAR DISEASE PATIENTS WITH VARYING RISK PROFILES IN SWEDEN
    Lindgren, P.
    Hagstrom, E.
    van Hout, B.
    Villa, G.
    Pemberton-Ross, P.
    Arellano, J.
    Sibartie, M.
    Fonarow, G. C.
    VALUE IN HEALTH, 2019, 22 : S548 - S548
  • [27] Cost-effectiveness of Evolocumab in Cardiovascular Disease: A Systematic Review
    Ghadimi, Nashmil
    Daroudi, Rajabali
    Shabaninejad, Hosein
    Goharimehr, Mahshad
    Khodamorzideh, Davoud
    Kaveh, Sara
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 2024, 101
  • [28] Impact of Cardiovascular Disease on Clinical Outcomes in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndrome
    Sanchez-Petitto, Gabriela
    Goloubeva, Olga
    Childress, James
    Iqbal, Tahreem
    Masur, Jack
    An, Max
    Muhammad, Safwan
    Lawson, Justin
    Sahbaz, Jasmin
    Barr, Brian
    Duong, Vu H.
    Law, Jennie Y.
    Emadi, Ashkan
    Baer, Maria R.
    Niyongere, Sandrine
    BLOOD, 2020, 136
  • [29] Cost-Effectiveness of Evolocumab in Adult Patients with Atherosclerotic Cardiovascular Disease from Chinese Healthcare Perspective
    Wenwen Xie
    Yinyin Song
    Xiaomei Qin
    Pengfei Jin
    Advances in Therapy, 2023, 40 : 489 - 503
  • [30] Marital status and outcomes in patients with cardiovascular disease
    Dhindsa, Devinder Singh
    Khambhati, Jay
    Schultz, William M.
    Tahhan, Ayman Samman
    Quyyumi, Arshed A.
    TRENDS IN CARDIOVASCULAR MEDICINE, 2020, 30 (04) : 215 - 220
12345